The results demonstrated that the FOXQ1 expression level was high in pancreatic adenocarcinoma, liver hepatocellular carcinoma, colon adenocarcinoma, lung cancer, and thyroid carcinoma but low in other tumors, such as kidney cancer, breast invasive carcinoma, uterine corpus endometrial carcinoma, cholangiocarcinoma, and sarcoma (Figure 1C). Here, FOXQ1 is linked to lung cancer.